Giovannoni G, et al. Cladribine tablets in high disease activity (HDA) subgroups from the CLARITY study of patients with relapsing multiple sclerosis (RMS). EP1157. EAN 2017.
Bootcamp voor training in acute neurologie
mei 2024 | Dementie, Epilepsie, Hoofdpijn, Neuro-musculair, Neuro-vasculair